Recordati SpA (MIL:REC) Total Operating Expense: €1,086 Mil (TTM As of Mar. 2026)


MIL:REC Recordati SpA MIL:REC
94 GF Score
Price €51.50
GF Value €60.65
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Recordati SpA Total Operating Expense?

Recordati SpA MIL:REC 94 Total Operating Expense is €1,086 Mil as of Mar. 2026. GuruFocus rates MIL:REC with a GF Score™ of 94/100 and a GF Value™ of €60.65 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Recordati SpA's Total Operating Expense for the three months ended in Mar. 2026 was €279 Mil. Recordati SpA's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €1,086 Mil.

Recordati SpA Total Operating Expense Related Terms

Recordati SpA Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Recordati SpA's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Recordati SpA Total Operating Expense Chart

Recordati SpA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 647.15 792.41 856.86 940.40 1,067.94

Recordati SpA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 261.59 273.90 251.43 281.02 279.18
MIL:REC
94GF Score
Recordati SpA MIL:REC
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Recordati SpA Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,086 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €1,086 Mil mean?
Recordati SpA (MIL:REC) has a Total Operating Expense of €1,086 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Recordati SpA and its competitors.
Is Recordati SpA's Total Operating Expense too high?
Recordati SpA's current Total Operating Expense is €1,086 Mil. Overall, Recordati SpA has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Recordati SpA's Total Operating Expense compare to LLY and JNJ?
Recordati SpA's Total Operating Expense of €1,086 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Recordati SpA and its competitors. Recordati SpA's current Total Operating Expense is €1,086 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Recordati SpA stock overvalued right now?
Based on GuruFocus' analysis, Recordati SpA (MIL:REC) is currently considered Modestly Undervalued. The stock's GF Value™ is €60.65, compared to a current price of €51.50 — trading 15.1% below its estimated fair value. The current Total Operating Expense is €1,086 Mil. Recordati SpA's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Recordati SpA (MIL:REC), the current Total Operating Expense is €1,086 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Recordati SpA (MIL:REC) Overvalued in 2026?

Based on GuruFocus' analysis, Recordati SpA stock appears to be undervalued. The current stock price of €51.50 is trading 15.1% below its estimated GF Value™ of €60.65. GuruFocus considers Recordati SpA to be Modestly Undervalued.

Key valuation signals for MIL:REC:

  • Total Operating Expense: €1,086 Mil
  • GF Value™: €60.65 vs. price of €51.50 (15.1% below fair value)
  • GF Score™: 94/100 with 3 warning signs

No single metric tells the full story. See the MIL:REC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Recordati SpA Business Description

Address Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is engaged in the development, production, and marketing of pharmaceutical products or of pharmaceutical chemicals. The Company operates in a broad and diverse context, which includes general medicine, specialist medicine, self-medication, and rare diseases. In addition, it is also active in the field of urology, with treatments for benign prostatic hyperplasia and male functional disorders, and in psychiatry. The Company's only operating segment is the Specialty & Primary Care segment. Its geographic areas are Europe, Australasia, America, and Africa.
94GF Score

Get the complete analysis for MIL:REC

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€51.50
Price
€60.65
GF Value